» Articles » PMID: 15819693

The Intriguing Biology of the Tumour Necrosis Factor/tumour Necrosis Factor Receptor Superfamily: Players, Rules and the Games

Overview
Journal Immunology
Date 2005 Apr 12
PMID 15819693
Citations 253
Authors
Affiliations
Soon will be listed here.
Abstract

The members of the tumour necrosis factor (TNF)/tumour necrosis factor receptor (TNFR) superfamily are critically involved in the maintenance of homeostasis of the immune system. The biological functions of this system encompass beneficial and protective effects in inflammation and host defence as well as a crucial role in organogenesis. At the same time, members of this superfamily are responsible for host damaging effects in sepsis, cachexia, and autoimmune diseases. This review summarizes recent progress in the immunobiology of the TNF/TNFR superfamily focusing on results obtained from animal studies using gene targeted mice. The different modes of signalling pathways affecting cell proliferation, survival, differentiation, apoptosis, and immune organ development as well as host defence are reviewed. Molecular and cellular mechanisms that demonstrate a therapeutic potential by targeting individual receptors or ligands for the treatment of chronic inflammatory or autoimmune diseases are discussed.

Citing Articles

Vertebrate TNF Superfamily: Evolution and Functional Insights.

Marin I Biology (Basel). 2025; 14(1).

PMID: 39857285 PMC: 11762692. DOI: 10.3390/biology14010054.


RELT Is Upregulated in Breast Cancer and Induces Death in Breast Cancer Cells.

Batiste M, Joy B, Yee C, Cho L, Christensen A, Abed I Biomedicines. 2025; 12(12.

PMID: 39767574 PMC: 11727564. DOI: 10.3390/biomedicines12122667.


Targeting proprotein convertase subtilisin/kexin type 7 in macrophages as a therapeutic strategy to mitigate myocardial infarction-induced inflammation.

Moon S, Chung I, Yoon N, Jin J, Kweon H, Yoon W BMB Rep. 2024; 57(12):553-558.

PMID: 39622633 PMC: 11693601.


Prospects of compounds of herbal plants as anticancer agents: a comprehensive review from molecular pathways.

Situmorang P, Ilyas S, Nugraha S, Syahputra R, Nik Abd Rahman N Front Pharmacol. 2024; 15:1387866.

PMID: 39104398 PMC: 11298448. DOI: 10.3389/fphar.2024.1387866.


Oncolytic vaccinia virus harboring gene enhances viral replication and antitumor efficacy.

Gao C, Ying Q, Qiu Y, Ren N, Chen K, Zhou Y Mol Ther Oncol. 2024; 32(3):200823.

PMID: 39006946 PMC: 11239687. DOI: 10.1016/j.omton.2024.200823.


References
1.
Stuber E, Strober W, Neurath M . Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med. 1996; 183(2):693-8. PMC: 2192468. DOI: 10.1084/jem.183.2.693. View

2.
Grech A, Quinn R, Srinivasan D, Badoux X, Brink R . Complete structural characterisation of the mammalian and Drosophila TRAF genes: implications for TRAF evolution and the role of RING finger splice variants. Mol Immunol. 2001; 37(12-13):721-34. DOI: 10.1016/s0161-5890(00)00098-5. View

3.
Bean A, Roach D, Briscoe H, France M, Korner H, Sedgwick J . Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol. 1999; 162(6):3504-11. View

4.
Harrop J, Reddy M, Dede K, Brigham-Burke M, Lyn S, Tan K . Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J Immunol. 1998; 161(4):1786-94. View

5.
Elkon K, Marshak-Rothstein A . B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men. Curr Opin Immunol. 1996; 8(6):852-9. DOI: 10.1016/s0952-7915(96)80015-x. View